COVID-19 Pandemic - The government presents its daily update
QUÉBEC CITY, June 20, 2021 /CNW Telbec/ - The most recent data on the evolution of COVID-19, in the last 24 hours, in Québec show:
103 new cases, bringing the total number of people infected to 373,921;
361,352 people have recovered;
2 new deaths, for a total of 11,191 deaths:
0 deaths in the last 24 hours,
2 deaths between June 13 and June 18,
170 hospitalizations, for a decrease of 8;
39 people in intensive care, which remains stable compared to the previous day;
17,300 samples conducted on June 18.
Vaccination
75,770 doses administered are added, that is 70,291 doses in the last 24 hours and 5,479 doses before June 19, for a total of 7,325,411 doses administered in Québec. Outside Québec, a total of 17,655 doses were administered, for a cumulative total of 7,343,066 doses received by Quebecers.
8,285,035* doses received in total. * there is a slight difference from the doses received yesterday due to a system update.
Summary Data Evolution Table1
Date
Confirmed cases
Deaths2
Hospitalizations
Hospitalizations in intensive care
Tests performed
Administered doses of vaccine3
June 13
123
4
214 (-1)
54 (-4)
15,968
78,387
June 14
105
1
209 (-5)
50 (-4)
24,849
90,725
June 15
153
1
192 (-17)
45 (-5)
24,686
86,621
June 16
161
1
178 (-14)
41 (-4)
22,677
97,766
June 17
127
2
175 (-3)
39 (-2)
19,619
101,860
June 18
160
0
178 (+3)
39
17,300
89,597
June 19
103
0
170 (-8)
39
NA
70,291
1 Note that the majority of data are presented according to the day they were entered. They are extracted at 4 p.m. at the date shown and cover the preceding 24 hours. However, the availability of the data on samples involves an additional delay of 24 hours and these correspond to the number of samples taken on the date shown.
2 It should also be noted that the data prior to those of the last 24 hours presented in the column Deaths have been adjusted according to the actual dates of death. This explains the variation of some data compared to those presented in previous press releases. The daily death toll is influenced by the time required for the physician to report the death, the time required to complete the investigation to confirm that the death was attributable to COVID-19, and the entry into the system.
3 Note that the number of doses administered may be subject to daily readjustment for the previous days, due to catching up due to a delay in data entry.
A reminder concerning public health instructions:
To limit the spread of the coronavirus as much as possible, it is important to follow basic preventive measures such as hand washing, physical distancing, wearing a face covering and following the instructions in effect in your region.
Remember that in the event of symptoms, it is always essential to isolate yourself and consult one of the self-care guides or call 1-877-644-4545 (or the telephone code corresponding to the region concerned) to find out the measures to be taken.
HanxBio today announced that it has published a research article titled "Narazaciclib, a novel multikinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models" in the Nature...
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed two contracts to provide the radiology module of its enterprise imaging solution with two university medical centers in Germany?Universitätsklinikum Tübingen...
Today, 23 April 2024, the subscription period in SciBase Holding AB (publ) ('SciBase' or the 'Company') rights issue of units of up to approximately SEK 15 million commences (the 'Rights Issue'). The Rights Issue was resolved by the Board of...
Antech, the veterinary diagnostics company focused on partnering with veterinary professionals to predict, diagnose, and monitor wellness and disease, today announced the launch of the breakthrough in-hospital Nu.Q® Canine Cancer Test in Europe. A...
Red Arrow Therapeutics Inc. closed a $4.5M Seed Extension round, raising from four, top-tier institutional investors in Japan.
Participants of this round are:
Beyond Next Ventures Inc.The University of Tokyo Edge Capital Partners Co., Ltd.Keio...
Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma, a pharmaceutical company headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care...